Claudia Prinz

发表

LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1

Cameron S. Osborne, A. Fischer, C. von Kalle, 2003, Science.

Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo.

Christine Kinnon, Christof von Kalle, Dick de Ridder, 2007, The Journal of clinical investigation.

Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy.

Bruce Aronow, Christof von Kalle, Jean Weissenbach, 2007, The Journal of clinical investigation.

Efficient marking of human cells with rapid but transient repopulating activity in autografted recipients.

C. von Kalle, C. Eaves, H. Glimm, 2005, Blood.

therapy trial differentiation potential and self-renewal capacity in the SCID-X1 gene Clonal evidence for the transduction of CD34+ cells with lymphomyeloid

A. Fischer, F. Deist, M. Cavazzana‐Calvo, 2013 .

The fusogenic lipid phosphatidic acid promotes the biogenesis of mitochondrial outer membrane protein Ugo1

M. van der Laan, M. Wenk, X. Guan, 2015, The Journal of cell biology.

Mitochondrial protein turnover: role of the precursor intermediate peptidase Oct1 in protein stabilization

N. Pfanner, F. Lottspeich, J. Kellermann, 2011, Molecular biology of the cell.

Dissecting Membrane Insertion of Mitochondrial β-Barrel Proteins

Thomas Becker, Stephan Kutik, N. Pfanner, 2008, Cell.

Clonal evidence for the transduction of CD34+ cells with lymphomyeloid differentiation potential and self-renewal capacity in the SCID-X1 gene therapy trial.

C. von Kalle, A. Fischer, M. Cavazzana‐Calvo, 2005, Blood.

The Hsp70 homolog Ssb affects ribosome biogenesis via the TORC1-Sch9 signaling pathway

M. Mayer, C. Prinz, S. Rospert, 2017, Nature Communications.